Abstract
This single center analysis shows further improvement in the already excellent long-term, cadaveric renal allograft survival with Aza since the introduction of CsA. In contrast to the findings from the UCLA/UNOS multicenter registries, these results support other observations that the type of maintenance immunosuppression does indeed influence the long-term attrition rate of cadaveric, renal allografts.
MeSH terms
-
Adult
-
Azathioprine / therapeutic use
-
Cadaver
-
Cyclosporine / therapeutic use*
-
Female
-
Graft Survival / drug effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Kidney Transplantation / methods*
-
Kidney Transplantation / mortality
-
Kidney Transplantation / physiology*
-
Male
-
Middle Aged
-
Regression Analysis
-
Survival Rate
-
Time Factors
-
Transplantation, Homologous
Substances
-
Immunosuppressive Agents
-
Cyclosporine
-
Azathioprine